133 related articles for article (PubMed ID: 35339677)
1. Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated cohorts.
Camp J; Filla T; Glaubitz L; Kaasch AJ; Fuchs F; Scarborough M; Kim HB; Tilley R; Liao CH; Edgeworth J; Nsutebu E; López-Cortés LE; Morata L; Llewelyn MJ; Fowler VG; Thwaites G; Seifert H; Kern WV; Rieg S; ;
Clin Microbiol Infect; 2022 Aug; 28(8):1149.e1-1149.e9. PubMed ID: 35339677
[TBL] [Abstract][Full Text] [Related]
2. Impact of Immunosuppressive Agents on Clinical Manifestations and Outcome of Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Analysis in 2 Large, Prospectively Evaluated Cohorts.
Camp J; Glaubitz L; Filla T; Kaasch AJ; Fuchs F; Scarborough M; Kim HB; Tilley R; Liao CH; Edgeworth J; Nsutebu E; López-Cortés LE; Morata L; Llewelyn M; Fowler VG; Thwaites G; Seifert H; Kern WV; Kuss O; Rieg S
Clin Infect Dis; 2021 Oct; 73(7):1239-1247. PubMed ID: 33914861
[TBL] [Abstract][Full Text] [Related]
3. Increasing numbers and complexity of Staphylococcus aureus bloodstream infection-14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findings.
Mathé P; Göpel S; Hornuss D; Tobys D; Käding N; Eisenbeis S; Kohlmorgen B; Trauth J; Gölz H; Walker SV; Mischnik A; Peter S; Hölzl F; Rohde AM; Behnke M; Fritzenwanker M; Häcker G; Steffens B; Vehreschild M; Kramme E; Falgenhauer J; Peyerl-Hoffmann G; Seifert H; Rupp J; Gastmeier P; Imirzalioglu C; Tacconelli E; Kern W; Rieg S;
Clin Microbiol Infect; 2023 Sep; 29(9):1197.e9-1197.e15. PubMed ID: 37277092
[TBL] [Abstract][Full Text] [Related]
4. Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patients.
Rieg S; Joost I; Weiß V; Peyerl-Hoffmann G; Schneider C; Hellmich M; Seifert H; Kern WV; Kaasch A
Clin Microbiol Infect; 2017 Jun; 23(6):406.e1-406.e8. PubMed ID: 27615722
[TBL] [Abstract][Full Text] [Related]
5. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
[TBL] [Abstract][Full Text] [Related]
6. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes.
Sinclair MR; Souli M; Ruffin F; Park LP; Dagher M; Eichenberger EM; Maskarinec SA; Thaden JT; Mohnasky M; Wyatt CM; Fowler VG
Am J Kidney Dis; 2022 Mar; 79(3):393-403.e1. PubMed ID: 34303771
[TBL] [Abstract][Full Text] [Related]
8. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
9. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with rifampicin or fosfomycin in patients with Staphylococcus aureus bloodstream infection at high risk for complications or relapse: results of a large prospective observational cohort.
Rieg S; Ernst A; Peyerl-Hoffmann G; Joost I; Camp J; Hellmich M; Kern WV; Kaasch AJ; Seifert H
J Antimicrob Chemother; 2020 Aug; 75(8):2282-2290. PubMed ID: 32355950
[TBL] [Abstract][Full Text] [Related]
11. Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis.
Diego-Yagüe I; Mora-Vargas A; Vázquez-Comendador JM; Santamarina-Alcantud B; Fernández-Cruz A; Múñez-Rubio E; Gutiérrez-Villanueva A; Sanchez-Romero I; Moreno-Torres V; Ramos-Martínez A; Calderón-Parra J
Clin Microbiol Infect; 2023 Jun; 29(6):744-750. PubMed ID: 36773773
[TBL] [Abstract][Full Text] [Related]
12. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study.
Kaasch AJ; Rieg S; Kuetscher J; Brodt HR; Widmann T; Herrmann M; Meyer C; Welte T; Kern P; Haars U; Reuter S; Hübner I; Strauss R; Sinha B; Brunkhorst FM; Hellmich M; Fätkenheuer G; Kern WV; Seifert H;
Infection; 2013 Oct; 41(5):979-85. PubMed ID: 23539143
[TBL] [Abstract][Full Text] [Related]
13. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
Trials; 2015 Oct; 16():450. PubMed ID: 26452342
[TBL] [Abstract][Full Text] [Related]
14. Onset of symptoms, diagnostic confirmation, and occurrence of multiple infective foci in patients with Staphylococcus aureus bloodstream infection: a look into the order of events and potential clinical implications.
Smit J; Rieg SR; Wendel AF; Kern WV; Seifert H; Schønheyder HC; Kaasch AJ
Infection; 2018 Oct; 46(5):651-658. PubMed ID: 29949090
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study.
Smit J; López-Cortés LE; Kaasch AJ; Søgaard M; Thomsen RW; Schønheyder HC; Rodríguez-Baño J; Nielsen H
Clin Microbiol Infect; 2017 Jan; 23(1):27-32. PubMed ID: 27343816
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcomes of
Gompelman M; Tuinte RAM; Berrevoets MAH; Bleeker-Rovers CP; Wanten GJA
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066383
[No Abstract] [Full Text] [Related]
18. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
[TBL] [Abstract][Full Text] [Related]
19. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia.
Wiese L; Mejer N; Schønheyder HC; Westh H; Jensen AG; Larsen AR; Skov R; Benfield T;
J Infect; 2013 Sep; 67(3):199-205. PubMed ID: 23664855
[TBL] [Abstract][Full Text] [Related]
20. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores.
Kim SH; Park WB; Lee CS; Kang CI; Bang JW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2006 Jan; 12(1):13-21. PubMed ID: 16460541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
